IL33 and bronchopulmonary dysplasia: Another murine model induced BPD by the intra-amniotic injection of LPS (1 μg) to pregnant mice on day 16.5 of gestation, and pups administered with 0.2 μg recombinant mouse IL-33 i.p. on P7 exhibited aggravated BPD changes.